Our results revealed HSPD1 as a ubiquitous lung cancer dependency gene, which maintains the metabolic fitness and promotes growth/survival, thus highlighting it as an attractive therapeutic target for NSCLC. The gene discussed is HSPD1; the disease is non-small cell lung carcinoma.